Automated Analyzers Market Reaches $7.6 Billion In 2026: Forecast And Growth Opportunities
Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Automated Analyzers Market Growth Potential: How Will Market Size Shift Through 2030?
The automated analyzers market has shown significant growth in recent years. This market is set to expand from $5.39 billion in 2025 to $5.79 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.4%. Historically, the growth was influenced by factors including manual and semi-automated testing methods, limitations in laboratory workforce efficiency, an increase in clinical testing volumes, the expansion of diagnostic laboratories, and a reliance on conventional analyzers.
The automated analyzers market is projected to experience substantial expansion over the coming years. This market is set to reach a valuation of $7.6 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.0%. Key factors contributing to this growth during the projection period include advancements in fully automated analyzer technology, the incorporation of AI and big data analytics, an increasing need for rapid diagnostic tools, the broadening scope of genomics and proteomics research, and the uptake of point-of-care testing solutions. Significant trends anticipated in the forecast timeframe encompass the wider acceptance of automated laboratory systems, a growing requirement for high-throughput sample processing, the integration of multi-functional analyzers within laboratory settings, the expansion of clinical diagnostics and research applications, and improvements in the accuracy and standardization of analytical testing.
Get A Free Sample Report With In-Depth Market Insights:
Automated Analyzers Market Growth Backed By Core Demand Fundamentals
The increasing occurrence of chronic diseases is anticipated to propel the expansion of the automated analyzers market moving forward. This rise in chronic conditions is attributed to aging populations, unhealthy lifestyles, and increased urbanization globally. Automated analyzers are employed in chronic disease management to provide efficient and accurate diagnostic testing, facilitating early detection, ongoing monitoring, and effective treatment for conditions such as diabetes, cardiovascular diseases, and kidney disorders. For instance, in June 2023, a report published by Kidney Research UK, a UK-based non-profit organization, indicated that approximately 7.2 million people in the UK are living with chronic kidney disease, representing over 10% of the population. Among these, 3.25 million are in the advanced stages of the disease, with an additional 3.9 million in the early stages. By 2033, the number of individuals affected by chronic kidney disease is projected to rise to 7.61 million. Therefore, the growing prevalence of chronic diseases is driving the growth of the automated analyzers market.
Automated Analyzers Market Segment Analysis: What Are The Core Market Categories?
The automated analyzers market covered in this report is segmented –
1) By Type: Biochemistry Analyzers, Immuno-Based Analyzers, Hematology Analyzers, Other Types
2) By Sample Type: Blood, Urine, Serum, Plasma, Other Sample Types
3) By Application: Drug Discovery, Genomics, Proteomics, Bio Analysis, Clinical Diagnostics, Other Applications
4) By End User: Hospitals And Clinics, Diagnostic Laboratories, Pharmaceutical And Biotechnology Companies, Other End Users
Subsegments:
1) By Biochemistry Analyzers: Clinical Biochemistry Analyzers, Point-of-Care Biochemistry Analyzers, Integrated Biochemistry Systems
2) By Immuno-Based Analyzers: Immunoassay Analyzers, Enzyme-Linked Immunosorbent Assay (ELISA) Analyzers, Chemiluminescent Immunoassay (CLIA) Analyzers
3) By Hematology Analyzers: Automated Hematology Analyzers, Flow Cytometry-Based Hematology Analyzers, Complete Blood Count (CBC) Analyzers
4) By Other Types: Molecular Analyzers, Urinalysis Analyzers, Coagulation Analyzers
Automated Analyzers Market Growth Trends Reshaping The Competitive Landscape
Leading companies in the automated analyzers market are concentrating on developing innovative solutions, such as automated clinical chemistry analyzers, to elevate efficiency, accuracy, and throughput in diagnostic laboratories. These advanced instruments are utilized in labs to perform a wide array of chemical tests on blood and other bodily fluids with minimal human intervention, consequently boosting the effectiveness and precision of diagnostic testing. For example, in January 2024, Beckman Coulter, a US-based manufacturing company, introduced the DxC 500 AU Chemistry Analyzer, representing a state-of-the-art advancement in automated clinical chemistry. Equipped with over 120 high-quality assays, this analyzer is specifically engineered to significantly enhance the capabilities of satellite and independent community hospital labs. It integrates sophisticated automation, streamlined workflows, and standardized reagents to improve testing efficiency and facilitate clinical decision-making. By serving as a vital complement to central hub laboratories within healthcare systems that employ hub-and-spoke models, the DxC 500 AU enhances overall operational efficiency and expands access to essential testing services.
Automated Analyzers Market Competitive Overview And Top Companies
Major companies operating in the automated analyzers market are Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Honeywell International, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Tosoh Corporation, Agilent Technologies Inc., Grifols S.A., Xylem Inc., Hitachi High-Tech Corporation, Mindray, PerkinElmer Inc, bioMérieux SA, Sysmex Corporation, Bruker Corporation, Horiba Medical, Randox Laboratories Ltd., Nova Biomedical Corporation, Trinity Biotech Plc
View The Full Automated Analyzers Market Report:
Automated Analyzers Market Top Region: Where Does Most Revenue Come From?
North America was the largest region in the automated analyzers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated analyzers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
